These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34457055)

  • 21. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
    Zhang Y; Dun Y; Zhou S; Huang XH
    Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GOLPH3 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in epithelial ovarian cancer.
    Sun J; Yang X; Zhang R; Liu S; Gan X; Xi X; Zhang Z; Feng Y; Sun Y
    Cancer Med; 2017 Apr; 6(4):834-844. PubMed ID: 28332316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mdig suppresses epithelial-mesenchymal transition and inhibits the invasion and metastasis of non‑small cell lung cancer via regulating GSK-3β/β-catenin signaling.
    Geng F; Jiang Z; Song X; Zhou H; Zhao H
    Int J Oncol; 2017 Dec; 51(6):1898-1908. PubMed ID: 29039479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salinomycin repressed the epithelial-mesenchymal transition of epithelial ovarian cancer cells via downregulating Wnt/β-catenin pathway.
    Li R; Dong T; Hu C; Lu J; Dai J; Liu P
    Onco Targets Ther; 2017; 10():1317-1325. PubMed ID: 28280366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
    Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
    Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis.
    Nguyen VHL; Hough R; Bernaudo S; Peng C
    J Ovarian Res; 2019 Dec; 12(1):122. PubMed ID: 31829231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wnt/β-catenin/Slug pathway contributes to tumor invasion and lymph node metastasis in head and neck squamous cell carcinoma.
    Moon JH; Lee SH; Lim YC
    Clin Exp Metastasis; 2021 Apr; 38(2):163-174. PubMed ID: 33630219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy.
    Zhang C; Zhang Z; Zhang S; Wang W; Hu P
    Med Sci Monit; 2017 Jan; 23():266-275. PubMed ID: 28090074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CK19 Promotes Ovarian Cancer Development by Impacting on Wnt/β-Catenin Pathway.
    Lu Q; Qu H; Lou T; Liu C; Zhang Z
    Onco Targets Ther; 2020; 13():2421-2431. PubMed ID: 32273715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indoxyl Sulfate Promotes Metastatic Characteristics of Ovarian Cancer Cells via Aryl Hydrocarbon Receptor-Mediated Downregulation of the Mas Receptor.
    Saito S; Koya Y; Kajiyama H; Yamashita M; Nawa A
    Lab Invest; 2023 Mar; 103(3):100025. PubMed ID: 36925201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of RIF1 Enhances Sensitivity to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC) by Regulating Nucleotide Excision Repair (NER) Pathway.
    Liu YB; Mei Y; Tian ZW; Long J; Luo CH; Zhou HH
    Cell Physiol Biochem; 2018; 46(5):1971-1984. PubMed ID: 29719287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oridonin inhibits pancreatic cancer cell migration and epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling pathway.
    Liu QQ; Chen K; Ye Q; Jiang XH; Sun YW
    Cancer Cell Int; 2016; 16():57. PubMed ID: 27453691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA SNHG1 is an unfavorable prognostic factor and promotes cell proliferation and migration by Wnt/β-catenin pathway in epithelial ovarian cancer.
    Wang S; Jiang J; Wang Z; Xie Y; Wu X
    Int J Clin Exp Pathol; 2017; 10(9):9284-9292. PubMed ID: 31966800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA MALAT1 regulates ovarian cancer cell proliferation, migration and apoptosis through Wnt/β-catenin signaling pathway.
    Guo C; Wang X; Chen LP; Li M; Li M; Hu YH; Ding WH; Wang X
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3703-3712. PubMed ID: 29949143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Songorine suppresses cell growth and metastasis in epithelial ovarian cancer via the Bcl‑2/Bax and GSK3β/β‑catenin signaling pathways.
    Zhang H; Dong R; Zhang P; Wang Y
    Oncol Rep; 2019 May; 41(5):3069-3079. PubMed ID: 30896826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-19a-3p regulates the Forkhead box F2-mediated Wnt/β-catenin signaling pathway and affects the biological functions of colorectal cancer cells.
    Yu FB; Sheng J; Yu JM; Liu JH; Qin XX; Mou B
    World J Gastroenterol; 2020 Feb; 26(6):627-644. PubMed ID: 32103872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting RPL23 restores chemosensitivity of cisplatin-resistant ovarian carcinoma by inhibiting EMT.
    Liu Y; Lai S; He J; Wan J; Fu F; Jinlong Y
    Cytotechnology; 2022 Jun; 74(3):421-432. PubMed ID: 35733701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SMIFH2-mediated mDia formin functional inhibition potentiates chemotherapeutic targeting of human ovarian cancer spheroids.
    Ziske MA; Pettee KM; Khaing M; Rubinic K; Eisenmann KM
    Biochem Biophys Res Commun; 2016 Mar; 472(1):33-9. PubMed ID: 26898799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
    Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
    Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
    Shi L; Xi J; Xu X; Peng B; Zhang B
    Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.